No. 48#, Yingxiongshan Road, 
Jinan, CN 

Overview

Fang Sha practices practicing medicine in Jinan, China.

Their clinical expertise encompasses Ectropion, Nearsightedness, Glaucoma, and Ocular Hypertension (OHT).

They are actively involved in clinical research, co-authoring 9 peer reviewed articles.

Locations

No. 48#, Yingxiongshan Road, Jinan, 250002, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


Frequently Asked Questions about Fang Sha

Is Fang Sha a top-rated expert for Ectropion?

MediFind is an objective health platform that identifies experts based on real-world data. Fang Sha is classified as an Experienced expert for Ectropion, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Fang Sha participate in research or clinical trials?

Yes. Fang Sha has published 9 articles and abstracts on conditions like Ectropion. You can view a list of Fang Sha's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Sha's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile